• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • 2.0 LPBI Brochure
  • Coronavirus, SARS-CoV-2 Portal
  • Knowledge PORTALS System (KPS)
  • Journal PharmaceuticalIntelligence.com
  • 2020-21 VISTA 1.0 LPBI
  • LPBI Group’s History
  • 2020-21 VISION – 2.0 LPBI
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • LPBI Group News
  • CALENDAR
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2020 Summer Internship Portal
  • 2021 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

e-Proceedings and Tweet Collections per Conference, 2013-2020, # Views = Downloads x $100: Real Time Coverage of 60 Events by ALA & SJW 

e-Proceedings and Tweet Collections per Conference, 2013-2020, # Views = Downloads x $100: Real Time Coverage of 60 Events by ALA & SJW

Curators: Aviva Lev-Ari, PhD, RN and Stephen J Williams, PhD

 

  • The data presented below is compiled from the following sources.

  • Views per documents published in realtime at the events fetched from the Site statistics on 2/2020.

Press Coverage is a Service that we offer to Biotech and Medicine, Scientific and Business Conference Organizers.

 

Click on these Links

 

  • Part One: The Process of Real Time Coverage using Social Media

  • Part Two: List of BioTech Conferences 2013 to Present

  • Part Three: Conference eProceedings DELIVERABLES & Social Media Analytics

 

 

  • 60 eProceedings & 36 Collections of Tweets, 2013 – 2019

REVENUE POTENTIAL FROM downloads of 96 items –

Valuation of the Archives based downloads = Views = 13,685)

@ $100 per download $1,368,500

YEAR            Tweet Collections (TC)       

# of Views

$ Grand Total 

e-Proceedings & Tweet Collections  

$

Grand Total Views
     Total               Aviva Lev-Ari & Stephen J Williams 1,090 109,000 1,368,500 13,685
Fraction – ALA 96% 84%
Fraction – SJW 4% 16%
YEAR            TC             # of Views $ Grand Total $ Grand Total Views
Total                       Aviva Lev-Ari 1,051 105,100 1,150,100 11,501
2020
2019 264 26,400
2018 213 21,300
2017 88 8,800
2016 246 24,600
2015 104 10,400
2014-2013 136 13,600
YEAR            TC             # of Views $ Grand Total $ Grand Total Views
Total                       Stephen J Willams 39 3,900 218,400 2,184
2020
2019
2018 22 2,200
2016-2017
2015 17 1,700
2014-2013

YEAR # Events Covered generating e-Proceedings (some events covered by iPhone Tweeting Pictures and Comments, only) Event counted as 1 even if it generated multiple article entires      e-Proceedings       # of Views $                

 

 

   Tweets Collections       (TC) generated         # Items
     Total               Aviva Lev-Ari & Stephen J Williams 60 12,595 1,259,500 36
Fraction – ALA 77% 83% 94%
Fraction – SJW 23% 17% 6%
YEAR # Events Covered generating e-Proceeding (some events covered by iPhone Tweeting Pictures and Comments, only) Event counted as 1 even if it generated multiple article entires      e-Proceedings       # of Views $    Tweets Collections       (TC) generated         # Items
Total                       Aviva Lev-Ari 46 10,450 1,045,000 34
2020 1 1
2019 11 955 95,500 8
2018 8 1,120 112,000 7
2017 5 469 46,900 3
2016 8 2,287 228,700 7
2015 5 2,383 238,300 5
2014-2013 8 3,236 323,600 3
YEAR # Events Covered generating e-Proceeding (some events covered by iPhone Tweeting Pictures and Comments, only) Event counted as 1 even if it generated multiple article entires      e-Proceedings       # of Views $    Tweets Collections       (TC) generated         # Items
Total                       Stephen J Willams 14 2,145 214,500 2
2020 1 61 6,100
2019 2 438 43,800
2018 2 352 35,200 1
2016-2017 3 105 10,500
2015 4 672 67,200 1
2014-2013 2 517 51,700

 

YEAR             Tweet Collections   # of Views $ Grand Total $ Grand Total Views

     Total               Aviva Lev-Ari & Stephen J Williams

1,090

109,000

1,368,500

13,685

Fraction – ALA 96% 84%
Fraction – SJW 4% 16%
YEAR           Tweet Collections   # of Views $ Grand Total $ Grand Total Views
Total                       Aviva Lev-Ari 1051 105100 1,150,100 11,501
2020
2019 264 26,400
2018 213 21,300
2017 88 8,800
2016 246 24,600
2015 104 10,400
2014-2013 136 13,600
YEAR           Tweet Collections   # of Views $ Grand Total $ Grand Total Views
Total                       Stephen J Willams 39 3,900 218,400 2,184
2020
2019
2018 22 2,200
2016-2017
2015 17 1,700
2014-2013

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Print
  • Email

Like this:

Like Loading...

  • Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,053 other followers

  • Recent Posts

    • Allon Klein, Harvard Medical School, and Aviv Regev, Genentech, Recipients of National Academy of Sciences James Prize in Science and Technology Integration 2021 Award  January 19, 2021
    • World Leaders to meet during Davos Agenda in a crucial year to rebuild trust January 18, 2021
    • Joe Biden Announced Science Team Nominations for the New Administration January 17, 2021
    • Potential Interest in LPBI Group’s BioMed e-Series January 17, 2021
    • Dysregulation of ncRNAs in association with Neurodegenerative Disorders January 11, 2021
    • Early Details of Brain Damage in COVID-19 Patients January 9, 2021
    • Cancer treatment using CRISPR-based Genome Editing System January 9, 2021
    • e-Voices Podcasting by LPBI: Celebrating Podcast #3 in an Audio Library on leading Scientists and Key Opinion Leaders in Biological Sciences January 9, 2021
    • Retrospective Study of National Danish Registry Sheds Light on Cardiotoxic Risks of Immune Checkpoint Inhibitors January 8, 2021
    • Leaders in Pharmaceutical Business Intelligence & youngStartup Ventures: Venture Summit Virtual Connect West, March 16th -18th 2021 featuring a dedicated Lifesciences / Healthcare Track   January 6, 2021
  • Archives

  • Categories

  • Meta

    • Register
    • Log in
    • Entries feed
    • Comments feed
    • WordPress.com
    • 2012pharmaceutical
    • Amandeep Kaur
    • Aashir Awan, Phd
    • Adina Hazan
    • Alan F. Kaul, PharmD., MS, MBA, FCCP
    • alexcrystal6
    • anamikasarkar
    • apreconasia
    • aviralvatsa
    • David Orchard-Webb, PhD
    • danutdaagmailcom
    • Demet Sag, Ph.D., CRA, GCP
    • Daniel Menzin
    • Dror Nir
    • dsmolyar
    • evelinacohn
    • Gail S Thornton
    • Irina Robu
    • jayzmit48
    • jdpmd
    • jshertok
    • kellyperlman
    • Ed Kislauskis
    • larryhbern
    • Madison Davis
    • marzankhan
    • megbaker58
    • ofermar2020
    • pkandala
    • Rosalind Codrington, PhD
    • ritusaxena
    • Rick Mandahl
    • sjwilliamspa
    • stuartlpbi
    • Dr. Sudipta Saha
    • tildabarliya
    • zraviv06
    • zs22

Blog at WordPress.com.

WPThemes.


loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: